Jaime Latour-Pérez

Summary

Affiliation: Hospital Virgen de los Lirios
Country: Spain

Publications

  1. doi request reprint Cost effectiveness of fondaparinux in non-ST-elevation acute coronary syndrome
    Jaime Latour-Pérez
    Intensive Care and Coronary Unit, Hospital General Universitario de Elche, Elche, Spain
    Pharmacoeconomics 27:585-95. 2009
  2. doi request reprint [Thrombolysis in acute ischemic stroke in centers lacking a stroke unit: referral to reference center or on-site treatment?]
    J Latour-Perez
    Servicio de Medicina Intensiva, Hospital General Universitario de Elche, Elche, Alicante, Espana
    Med Intensiva 36:324-8. 2012
  3. doi request reprint Cost effectiveness of anticoagulation in acute coronary syndromes
    Jaime Latour-Pérez
    Intensive Care Unit, Hospital General Universitario de Elche, Elche, Spain
    Pharmacoeconomics 30:303-21. 2012
  4. doi request reprint [Early invasive strategy in non-ST-segment elevation acute coronary syndrome. The paradox continues]
    J Latour-Perez
    Servicio de Medicina Intensiva, Hospital General Universitario de Elche, Elche, Alicante, Espana
    Med Intensiva 36:95-102. 2012
  5. doi request reprint Diagnostic accuracy of sTREM-1 to identify infection in critically ill patients with systemic inflammatory response syndrome
    Jaime Latour-Pérez
    Hospital General Universitario de Elche, Servicio de Medicina Intensiva, Camí Vell de l Almàssera 11, 03203 Elche, Spain
    Clin Biochem 43:720-4. 2010
  6. doi request reprint [Prognostic value of the sTREM-1 plasma values in patients with sepsis: a cohort study]
    J Latour-Perez
    Servicio de Medicina Intensiva, Hospital General Universitario de Elche, Alicante, Espana
    Med Intensiva 34:231-6. 2010
  7. ncbi request reprint [Early interruption of clinical trials: too good to be true?]
    J Latour-Perez
    Servicio de Medicina Intensiva, Hospital General Universitario de Elche, Elche, Espana
    Med Intensiva 31:518-20. 2007
  8. ncbi request reprint [Effectiveness and safety of triple antiaggregation in patients undergoing coronary intervention]
    J Latour-Perez
    Servicio de Medicina Intensiva, Hospital General de Elche, Alicante
    Med Intensiva 31:220-30. 2007
  9. ncbi request reprint Using clopidogrel in non-ST-segment elevation acute coronary syndrome patients: a cost-utility analysis in Spain
    Jaime Latour-Pérez
    Intensive Care Unit, Hospital General Universitario de Elche, Department of Public Health Universidad de Alicante, Alicante, Spain
    Value Health 7:52-60. 2004
  10. doi request reprint Using triple antiplatelet therapy in patients with non-ST elevation acute coronary syndrome managed invasively: a cost-effectiveness analysis
    Jaime Latour-Pérez
    Intensive Care Unit, Hospital General Universitario de Elche, Elche, Spain
    Value Health 11:853-61. 2008

Detail Information

Publications11

  1. doi request reprint Cost effectiveness of fondaparinux in non-ST-elevation acute coronary syndrome
    Jaime Latour-Pérez
    Intensive Care and Coronary Unit, Hospital General Universitario de Elche, Elche, Spain
    Pharmacoeconomics 27:585-95. 2009
    ..Fondaparinux has been shown to reduce the risk of major bleeding and 30-day mortality compared with enoxaparin, in patients with non-ST-elevation acute coronary syndrome (NSTE-ACS). However, its cost effectiveness is not well known...
  2. doi request reprint [Thrombolysis in acute ischemic stroke in centers lacking a stroke unit: referral to reference center or on-site treatment?]
    J Latour-Perez
    Servicio de Medicina Intensiva, Hospital General Universitario de Elche, Elche, Alicante, Espana
    Med Intensiva 36:324-8. 2012
    ..To assess the clinical impact of on-site thrombolysis versus referral to another hospital in patients with ischemic stroke attended in a hospital lacking a stroke unit...
  3. doi request reprint Cost effectiveness of anticoagulation in acute coronary syndromes
    Jaime Latour-Pérez
    Intensive Care Unit, Hospital General Universitario de Elche, Elche, Spain
    Pharmacoeconomics 30:303-21. 2012
    ..Ever since, a wide variety of anticoagulant drugs have become available for clinical use, including low-molecular-weight heparins (LMWH), direct thrombin inhibitors and selective factor Xa inhibitors...
  4. doi request reprint [Early invasive strategy in non-ST-segment elevation acute coronary syndrome. The paradox continues]
    J Latour-Perez
    Servicio de Medicina Intensiva, Hospital General Universitario de Elche, Elche, Alicante, Espana
    Med Intensiva 36:95-102. 2012
    ..The study objectives are: 1) to examine the association between baseline risk in patients with NSTE ACS and the use of EIS; and 2) to identify some of the factors independently associated to the use of EIS...
  5. doi request reprint Diagnostic accuracy of sTREM-1 to identify infection in critically ill patients with systemic inflammatory response syndrome
    Jaime Latour-Pérez
    Hospital General Universitario de Elche, Servicio de Medicina Intensiva, Camí Vell de l Almàssera 11, 03203 Elche, Spain
    Clin Biochem 43:720-4. 2010
    ..To assess the accuracy of plasma levels of soluble Triggering Receptor Expressed on Myeloid cells (sTREM)-1 to diagnose infection in critical patients with systemic inflammatory response syndrome (SIRS)...
  6. doi request reprint [Prognostic value of the sTREM-1 plasma values in patients with sepsis: a cohort study]
    J Latour-Perez
    Servicio de Medicina Intensiva, Hospital General Universitario de Elche, Alicante, Espana
    Med Intensiva 34:231-6. 2010
    ..To evaluate the association between plasma levels of soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) and mortality of patients with sepsis...
  7. ncbi request reprint [Early interruption of clinical trials: too good to be true?]
    J Latour-Perez
    Servicio de Medicina Intensiva, Hospital General Universitario de Elche, Elche, Espana
    Med Intensiva 31:518-20. 2007
    ..Furthermore, clinicians should provide themselves with an adequate dose of skepticism and critical reading skills to enable them to explore some key aspects of these studies...
  8. ncbi request reprint [Effectiveness and safety of triple antiaggregation in patients undergoing coronary intervention]
    J Latour-Perez
    Servicio de Medicina Intensiva, Hospital General de Elche, Alicante
    Med Intensiva 31:220-30. 2007
    ....
  9. ncbi request reprint Using clopidogrel in non-ST-segment elevation acute coronary syndrome patients: a cost-utility analysis in Spain
    Jaime Latour-Pérez
    Intensive Care Unit, Hospital General Universitario de Elche, Department of Public Health Universidad de Alicante, Alicante, Spain
    Value Health 7:52-60. 2004
    ..The objective of this study was to estimate the cost-effectiveness of clopidogrel, administered for 1 year after hospital admission for non-ST-segment elevation acute coronary syndrome in the Spanish public health network...
  10. doi request reprint Using triple antiplatelet therapy in patients with non-ST elevation acute coronary syndrome managed invasively: a cost-effectiveness analysis
    Jaime Latour-Pérez
    Intensive Care Unit, Hospital General Universitario de Elche, Elche, Spain
    Value Health 11:853-61. 2008
    ....
  11. doi request reprint Prinzmetal's angina in a patient with angiosarcoma of the right cardiac chambers
    Anna Baeza-Román
    Servicio Medicina Intensiva, Hospital General Universitario de Elche, Alicante, Spain
    Heart Lung 40:346-8. 2011
    ..We describe a classic case of variant angina associated with an angiosarcoma of the right heart chambers...